Inclusion Criteria:
  -  Patients of any age with a diagnosis of familial dysautonomia (FD) with molecular confirmation of the IKBKAP mutation.
  -  Ability to provide informed consent (or assent) and comply with the study protocol
Exclusion Criteria:
  -  Subjects that do not wish to be a part of the study.